Name: New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells (Video) | JoVE Journal
Uploaded: 2017-10-09T15:00:00.000+00:00
Duration: 6 min 34 s
Description: Learn to apply low-dose helium atmospheric pressure plasma jets for neuroprotection in SH-SY5Y cells under glucose deprivation. This method reduces cellular injury and offers a cost-effective approach for ischemic brain research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by the Innovation fund of Beijing Neurosurgical Institute (2014-11), National Natural Science Foundation of China (Nos. 11475019 and 81271286) and Beijing Natural Science Foundation (No. 7152027).

1. Preparation of the APPJ device
CAUTION: Please consult all relevant material safety data sheets (MSDS) before use. Please use appropriate safety practices when performing all the&#160;experiments, including the use of a fume hood and personal protective equipment (safety glasses, protective gloves, lab coat, etc.). The protocol requires standard cell handling techniques (sterilizing, cell recovery, cell passaging, cell freezing, cell staining, etc.).
<ol>
	<li>Choose a quartz tube with an internal diameter of 1 mm and an external diameter of 3 mm. Smooth the cross-sections at both ends using a polishing foil.</li>
	<li>Use a Nickel-plated stainless-steel needle with a diameter of 1.0 mm as the high voltage electrode. Grind its tip to a radius of curvature of 0.05 mm.</li>
	<li>Wrap aluminum foil (2 mm in width) around the quartz tube at 1 cm from the quartz tube nozzle. Fix the stainless-steel needle point at 1 cm from the other end of the aluminum foil. Use the aluminum foil ring as the low voltage electrode.</li>
</ol>
2. Acquisition of Jets
<ol>
	<li>To provide an AC signal, connect the high-voltage power amplifier to the function signal generator that serves as a power supply. To record the waveforms of the applied voltage to the high voltage electrode, connect one end of the high-voltage probe to the digital oscilloscope and connect the other end to the power supply. To protect the circuit, use a 2 k&#8486; resistor as a protective resistor. Connect the circuit as shown in Figure 2. 
	CAUTION: Do not touch the high voltage lines.</li>
	<li>Continuously pass helium (volume fraction, 99.999%) over the quartz tube and control the gas flow rate at a stable 1.4 Standard Liter per Minute (SLM). 
	NOTE: We do not use a filter before treating cell cultures. The volume fraction of helium used in the experiment is 99.999%, and most microorganisms cannot live under these conditions.</li>
	<li>Turn on the power of the oscilloscope, signal generator, and high-voltage power amplifier. Rotate the frequency adjustment knob to 5 kHz. Gradually increase the voltage to a peak-to-peak value of 6 kV. 
	NOTE: The jet is long enough (approximately 3 cm) when the peak-to-peak value of the voltage applied in the needle is approximately 6 kV.</li>
</ol>
3. Preparation of SH-SY5Y Cells
<ol>
	<li>Grow the SH-SY5Y human neuroblastoma-derived cell line in a 25 cm2 flask in RPMI 1640 medium supplemented with 15% fetal calf serum (FBS). Maintain the cells in a humidified incubator containing 5% CO2 and 95% air at 37 &#176;C.</li>
	<li>When the cells reach 85% confluence, carefully aspirate the culture media and add 1 mL 0.25% trypsin + 0.1% EDTA to the cells.</li>
	<li>After 15 s incubation at room temperature, carefully aspirate the trypsin and add 2 mL RPMI 1640 containing 15% FBS to neutralize.</li>
	<li>Gently pipette up and down, washing the bottom of the well, until the SH-SY5Y monolayer is completely detached.</li>
	<li>Count the cells by means of the hemocytometer and adjust the cell concentration to 2 x 105 cells/mL by adding RPMI 1640 medium +15% FBS, and then transfer 100 &#181;L of cell suspension to each well of a 96-well plate.</li>
	<li>Allow the cells to attach for 12 h in a cell incubator before APPJ treatment.</li>
</ol>
4. APPJ treatment of SH-SY5Y
<ol>
	<li>Adjust the distance between the nozzle of the quartz tube and the platform where the 96-well plate will be placed to 3 cm. Ensure that the beam can touch the surface of the culture medium. 
	NOTE: The distance is not measured from the bottom of the plate. It is first adjusted to 3 cm between the nozzle of the quartz tube and the platform used to place 96-well plate.</li>
	<li>Before the APPJ treatment, change the culture medium in each well except the control wells to RPMI 1640 without glucose medium.</li>
	<li>Place the plate under the APPJ nozzle and ensure that the jets can shoot vertically into each well.</li>
	<li>Treat cells in separate wells with APPJ for 0 s, 1 s, 2 s, 4 s, 8 s, and 12 s. 
	NOTE: APPJ is generated by ionizing helium (Figure 1). The cells injured by glucose deprivation are treated by 4 s and 8 s helium flow to eliminate the effects of helium on cells. All the treatments should be performed in triplicate.</li>
</ol>
5. Cell Viability Assay
NOTE: Do not change the medium in this step.
<ol>
	<li>After the APPJ treatment, incubate the cells for 1 h in a cell incubator.</li>
	<li>Add 10 &#181;L of Cell Counting Kit-8 (CCK-8) solution to each well.</li>
	<li>Incubate the cells at 37 &#176;C for 4 h. 
	NOTE: The SH-SY5Y cell line is sensitive to glucose deprivation conditions12. Cell viability decreases to nearly 50% after 1 h glucose deprivation, which is the optimum cell viability condition for pharmacodynamics studies. CCK-8 has no cytotoxicity to cells and cells are incubated with CCK-8 reagent for another 4 h in the glucose deprivation conditions after APPJ treatment to check cell viability. After 8 h glucose deprivation and APPJ treatment, the protective effect of APPJ was significantly reduced because the long-duration of glucose deprivation led to severe damage of the SH-SY5Y cells. There was no evidence of living cells after 24 h glucose deprivation11.</li>
	<li>Measure the absorbance at 450 nm with a microplate reader.</li>
</ol>

<ol><li>Yang, S. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Alternative+mitochondrial+electron+transfer+for+the+treatment+of+neurodegenerative+diseases+and+cancers%3A+Methylene+blue+connects+the+dots%5BTitle%5D)+AND+%22Prog.+Neurobiol%22%5BJournal%5D)">Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.</a> Prog. Neurobiol. , (2015).</li>
<li>Bhat, A. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Oxidative+stress%2C+mitochondrial+dysfunction+and+neurodegenerative+diseases%3B+a+mechanistic+insight%5BTitle%5D)+AND+%22Biomed.+Pharmacother%22%5BJournal%5D)">Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight.</a> Biomed. Pharmacother. 74, 101-110 (2015).</li>
<li>Bullon, P., Newman, H. N., Battino, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Obesity%2C+diabetes+mellitus%2C+atherosclerosis+and+chronic+periodontitis%3A+a+shared+pathology+via+oxidative+stress+and+mitochondrial+dysfunction%3F%5BTitle%5D)+AND+%22Periodontol.+2000%22%5BJournal%5D)">Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction?</a> Periodontol. 2000. 64 (1), 139-153 (2014).</li>
<li>Sutherland, B. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Neuroprotection+for+ischaemic+stroke%3A+translation+from+the+bench+to+the+bedside%5BTitle%5D)+AND+%22International+Journal+of+Stroke%22%5BJournal%5D)">Neuroprotection for ischaemic stroke: translation from the bench to the bedside.</a> International Journal of Stroke. 7 (5), 407-418 (2012).</li>
<li>Yan, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Principles+of+using+Cold+Atmospheric+Plasma+Stimulated+Media+for+Cancer+Treatment%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">Principles of using Cold Atmospheric Plasma Stimulated Media for Cancer Treatment.</a> Scientific Reports. 5 (5), 18339(2015).</li>
<li>Lu, X., Laroussi, M., Puech, V. <a target="_blank" href="http://iopscience.iop.org/article/10.1088/0963-0252/21/3/034005/meta">On atmospheric-pressure non-equilibrium plasma jets and plasma bullets.</a> Plasma Sources Science & Technology. 21 (3), 034005(2012).</li>
<li>Lu, X., et al. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0370157316300187">Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects.</a> Phys. Rep. 630, 1-84 (2016).</li>
<li>Lu, X., Naidis, G. V., Laroussi, M., Ostrikov, K. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0370157314000441">Guided ionization waves: Theory and experiments.</a> Phys. Rep. 540 (3), 123-166 (2014).</li>
<li>Di, M. S., Reed, T. T., Venditti, P., Victor, V. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+ROS+and+RNS+Sources+in+Physiological+and+Pathological+Conditions%5BTitle%5D)+AND+%22Oxid.+Med.+Cell+Longev%22%5BJournal%5D)">Role of ROS and RNS Sources in Physiological and Pathological Conditions.</a> Oxid. Med. Cell Longev. 2016 (22), 1245049(2016).</li>
<li>Contestabile, A., Ciani, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+nitric+oxide+in+the+regulation+of+neuronal+proliferation%2C+survival+and+differentiation%5BTitle%5D)+AND+%22Neurochemistry+International%22%5BJournal%5D)">Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation.</a> Neurochemistry International. 45 (6), 903-914 (2004).</li>
<li>Yan, X., et al. <a target="_blank" href="http://iopscience.iop.org/article/10.1088/1361-6463/aa5603">Protective effect of atmospheric pressure plasma on oxidative stress-induced neuronal injuries: an in vitro study.</a> J. Phys. D: Appl. Phys. 50 (9), 095401(2017).</li>
<li>Xie, H. R., Hu, L. S., Li, G. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((SH-SY5Y+human+neuroblastoma+cell+line%3A+in+vitro+cell+model+of+dopaminergic+neurons+in+Parkinson%27s+disease%5BTitle%5D)+AND+%22Chin.+Med.+J%22%5BJournal%5D)">SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.</a> Chin. Med. J. 123 (8), 1086-1092 (2010).</li>
<li>Tsutsui, C., et al. <a target="_blank" href="http://iopscience.iop.org/article/10.7567/JJAP.53.060309/pdf">Treatment of cardiac disease by inhalation of atmospheric pressure plasma.</a> Japanese Journal of Applied Physics. 53 (6), 060309(2014).</li>
<li>Graves, D. B. <a target="_blank" href="http://aip.scitation.org/doi/abs/10.1063/1.4892534">Low temperature plasma biomedicine: A tutorial review.</a> Physics of Plasmas. 21 (8), 104-117 (2014).</li>
</ol>

No conflicts of interest were declared in relation to this paper.

SH-SY5Y cells are a human neuroblastoma-derived cell line and are widely used as an appropriate cell model for in vitro studies on neurotoxicity or neuroprotection12. The SH-SY5Y cell line was sensitive to glucose deprivation conditions. Cell viability decreased to nearly 50% after 1 h glucose deprivation, which is the optimal cell viability condition for studies of pharmacodynamics. Furthermore, CCK-8 reagent has no cytotoxicity to cells and cells were incubated with CCK-8 reagent for an...

The adult brain almost exclusively uses glucose as a substrate for energy metabolism under normal physiological conditions. The human brain constitutes only 2% of the body weight but consumes approximately 25% of the total glucose within the body1. It is well documented that glucose metabolism dysfunction is one of the major pathological changes during ischemic stroke and various neurodegenerative diseases, including Alzheimer&#39;s disease (AD), Huntington&#39;s disease (HD), and Parkinson&#39;s disease (PD)2,3. The lack of glucose and either impaired glucose uptake or oxidative phosphorylation can directly impact ATP production and further induce neural cell death, which may increase the risk of neuronal dysfunction, suggesting that maintaining cell viability or delaying cell injury after glucose deprivation might be a reasonable approach for treating these diseases. The investigation of neuroprotective effects via glucose modulation, focusing on anti-inflammatory agents, ion channel modulators, free radical scavengers, neurotrophic factors, etc. has been of interest. However, translation of these neuroprotective approaches from bench to clinical practice has not been successful4.
Atmospheric pressure plasma jets (APPJs) are a new kind of atmospheric low temperature gas discharge technology that has attracted the attention of many researchers from multiple disciplines in recent years. APPJs have been used for decades in various biomedical applications such as cancer cell treatment, bacterial inactivation, blood coagulation, wound healing, oral medicine, etc.5,6, due to its emissions of multiple types of reactive nitrogen species (RNS) and reactive oxygen species (ROS) (Figure 1)7. Previous plasma bio-medicine applications mainly focused on the oxidative and/or nitrative stress on bacteria, cells, and tissues8. However, the APPJ could also be a &#34;double-edged sword&#34; since RNS and ROS are important intracellular signaling molecules related to many physiological and pathophysiological processes9. Nitrous oxide (NO) controls a wide range of biological processes and plays a dual role in the human body, especially in central nervous system (CNS). Low levels of NO have shown their neuroprotective activities both in vitro and in vivo via multiple signal pathways10. Our previous study first reported that helium APPJ-induced NO production was involved in the neuroprotective effect of APPJ against oxidative stress-induced injuries11. However, the effects of APPJs on other injuries have not been reported. Therefore, the aim of the present study is to provide an in vitro treatment protocol regarding the neuroprotective applications of helium APPJ on glucose deprivation-induced injury in SH-SY5Y cells. Different from previous studies, our protocol used low-dose plasma treatment for neuroprotective applications without the consequences of excessive plasma-induced injuries, indicating that the APPJ treatment could be potentially used as a novel &#34;NO donor drug&#34; for future research and even for clinical translation. This protocol was also suggested to be used as a cytoprotective application for other cell types with different impairments, but the APPJ treatment conditions should be re-adjusted and the treatment dose must be relatively low.

<table><tbody><tr><td>SH-SY5Y cell line</td><td>China Center for Type Culture Collection</td><td>3111C0001CCC000026</td><td></td></tr><tr><td>RPMI 1640 medium</td><td>Thermo Scientific</td><td>21875091</td><td>stored at 4 &amp;deg;C</td></tr><tr><td>RPMI 1640 medium no glucose</td><td>Thermo Scientific</td><td>11879020</td><td>stored at 4 &amp;deg;C</td></tr><tr><td>fetal calf serum</td><td>Thermo Scientific</td><td>16000044</td><td>stored at -20 &amp;deg;C</td></tr><tr><td>tripsin-EDTA solution</td><td>Solarbio</td><td>T1300</td><td>stored at 4 &amp;deg;C</td></tr><tr><td>96 wells plate</td><td>corning</td><td>3599</td><td></td></tr><tr><td>Cell Counting Kit-8 (CCK-8)</td><td>Dojindo Laboratories</td><td>CK04</td><td>stored at 4 &amp;deg;C</td></tr><tr><td>microplate reader</td><td>Tecan</td><td>M200 Pro</td><td>for measuring the absorbance at 450 nm</td></tr><tr><td>High &amp;ndash; voltage Power Amplifier</td><td>Trek</td><td>PD06087</td><td>for amplifing the power</td></tr><tr><td>Function Signal Generator</td><td>MaZe Electronics Science&amp;amp;Technology</td><td>AT30120</td><td>for providing the specific signal</td></tr><tr><td>High &amp;ndash; Voltage Probe</td><td>Tektronix</td><td>P6015A</td><td>for detecting high voltage</td></tr><tr><td>Digital Oscilloscope</td><td>Tektronix</td><td>DPO4104B</td><td>for displaying the signal</td></tr></tbody></table>

new application of an atmospheric pressure plasma jet as a neuro-protective agent against glucose deprivation-induced injury of sh-sy5y cells

New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells

The atmospheric pressure plasma jet (APPJ) has attracted the attention of many researchers from multiple disciplines in recent years because its emissions include multiple types of reactive nitrogen species (RNS) and reactive oxygen species (ROS). Our previous study has shown the cytoprotective effect of the APPJ against oxidative stress-induced injuries. The aim of the present study is to provide a detailed in vitro treatment protocol regarding the neuroprotective applications of helium APPJs on glucose deprivation-induced injury in SH-SY5Y cells. The SH-SY5Y human neuroblastoma-derived cell line was maintained in RPMI 1640 medium supplemented with 15% fetal calf serum. The culture medium was then changed to RPMI 1640 without glucose before APPJ treatment. After a 1 h incubation in a cell incubator, cell viability was determined using Cell Counting Kit 8. The results showed that, compared to the glucose deprivation group, cells treated with APPJ exhibited significantly increased cell viability in a dose-dependent manner, with 8 s/well observed as an optimal dose. Meanwhile, helium flow had no effect on the glucose deprivation-induced cell impairment. Our results indicated that APPJ could be potentially used as a treatment method for the diseases in the central nervous system related to glucose deprivation. This protocol could also be used as a cytoprotective application for other cells with different impairments, but the cell culture and APPJ treatment conditions should be readjusted, and the treatment dose must be relatively low.

Data are expressed as the mean ± SD of at least three independent experiments. Group results were analyzed for variance using ANOVA. All analyses were performed using statistical analysis software Prism and p&lt;0.05 was the threshold for statistical significance.
Cell viability was measured after 4 h of CCK-8 incubation. As shown in Figure 3, glucose deprivation reduced the viability of SH-SY5Y cells to 44.1 ± 2.6% compared to that of the control group (cells nor...

A protocol for the neuroprotective application of low-dose atmospheric pressure plasma treatment on glucose deprivation-induced SH-SY5Y injuries.

The atmospheric pressure plasma jet (APPJ) has attracted the attention of many researchers from multiple disciplines in recent years because its emissions ...

new-application-an-atmospheric-pressure-plasma-jet-as-neuro

Research

JoVE Journal

Engineering

A novel impulsive cell pressurization experiment has been developed using a Kolsky bar device to investigate the molecular/cellular mechanisms of blast-induced traumatic brain injury.

Impulsive Pressurization of Neuronal Cells for Traumatic Brain Injury Study

Take a mouse subjected to laser-induced damage to the optic nerve head in the eye.The damage causes endothelial cell injury and blood clot formation in the blood vessels supplying the nerve, reducing blood flow and causing ischemia.Ischemia deprives the retinal ganglion cell axons in the optic nerve head of oxygen.In the RGC cell bodies, this disruption impairs mitochondrial function and increases reactive oxygen species production.The resulting oxidative stress activates apoptotic signaling...

 Hyperbaric Oxygen Therapy as a Neuroprotective Strategy for Anterior Ischemic Optic Neuropathy

This video presents a method for triggering differentiation in neural stem cells by utilizing cold atmospheric plasma. This generates UV radiation and reactive molecules to stimulate nerve cells to produce projections, indicating neuronal cell differentiation.

Stimulating Nerve Stem Cell Differentiation Using Cold Atmospheric Plasma Treatment

Source: Yan, X., et. al., New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells. J. Vis. Exp. (2017)The video demonstrates the neuroprotective activity of low-dose atmospheric pressure plasma treatment in glucose-deprived neuroblastoma cells by modulating oxidative stress and enhancing cell viability.

Assessing Atmospheric Pressure Plasma Treatment in Glucose-Deprived Neuroblastoma Cells 

Acute brain trauma is a severe injury that has no adequate treatment to date. Multiphoton microscopy allows studying longitudinally the process of acute brain trauma development and probing therapeutical strategies in rodents. Two models of acute brain trauma studied with in vivo two-photon imaging of brain are demonstrated in this protocol.

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Treating cervical spinal cord injury with both self-assembling peptides (SAP) and neural precursor cells (NPC), together with growth factors, is a promising approach to promote regeneration and recovery. A contusion/compression aneurysm clip rat model of cervical SCI and combined treatment involving SAP injection and NPC transplantation is established.

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Ischemic stroke is a complex event in which the specific contribution of astrocytes to the affected brain region exposed to oxygen glucose deprivation (OGD) is difficult to study. This article introduces a methodology to obtain isolated astrocytes and study their reactivity and proliferation under OGD conditions.

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions

Acidic postconditioning protects against cerebral ischemia. Here we present two models to execute APC. They are achieved respectively by transferring corticostriatal slices to acidic buffer after oxygen-glucose deprivation in vitro and by inhaling 20% CO2 after middle cerebral artery occlusion in vivo.

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

This protocol aims to provide detailed experimental steps of a cold atmospheric plasma treatment on neural stem cells and immunofluorescence detection for differentiation enhancement.

Nerve Stem Cell Differentiation by a One-step Cold Atmospheric Plasma Treatment In Vitro

The goal of the protocol is to provide a method for producing non-invasive neuronal lesions in the brain. The method utilizes Magnetic Resonance-guided Focused Ultrasound (MRgFUS) to open the Blood Brain Barrier in a transient and focal manner, in order to deliver a circulating neurotoxin to the brain parenchyma.

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

This work describes the development of flexible interdigitated electrodes for implementation in 3D brain tumor models, namely, in vitro culture, in ovo model, and in vivo murine model. The proposed method can be used to evaluate the effects of pulsed electric fields on tumors at different levels of complexity.

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Learn to apply low-dose helium atmospheric pressure plasma jets for neuroprotection in SH-SY5Y cells under glucose deprivation. This method reduces cellular injury and offers a cost-effective approach for ischemic brain research.

New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells (Video) | JoVE Journal

New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells

Explore More Videos